SOBR Safe, Inc.
For the period ended Dec 31, 2025. Filed Apr 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 10, 2026
SOBR$0.20-48.0%Stored close · as of Sep 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 15. –EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a)(1) Financial Statements
For a list of financial statements and supplementary data filed as part of this Annual Report, see the Index to Financial Statements beginning at page F-1 of this Annual Report.
(a)(2) Financial Statement Schedules
We do not have any financial statement schedules required to be supplied under this Item.
(a)(3) Exhibits
Refer to (b) below.
(b) Exhibits
| Exhibit · Reference · Filed or Furnished | |||||
|---|---|---|---|---|---|
| Number | Exhibit Description | Form | Exhibit | Filing Date | Herewith |
| 3.1 | Certificate of Incorporation of Imagine Media, Ltd. | SB-2 | 3.1 | 01/31/2008 | |
| 3.2 | Certificate of Amendment to Articles of Incorporation to TransBiotec, Inc. | S-1 | 3.2 | 11/06/2012 | |
| 3.3 | Certificate of Amendment to Certificate of Incorporation filed with the State of Delaware on May 25, 2017 | 10-K | 3.3 | 02/06/2019 | |
| 3.4 | Amended and Restated Bylaws of SOBR Safe, Inc. | 8-K | 3.2 | 07/18/2025 | |
| 3.5 | Certificate of Amendment to Certificate of Incorporation of TransBiotec, Inc. changing name to SOBR Safe, Inc., effecting 1-for-33.26 reverse stock split and decreasing authorized common stock to 100M shares | 8-K | 3.1 | 06/11/2020 | |
| 3.6 | Amendment to Amended and Restated Bylaws of SOBR Safe, Inc. dated April 6, 2023 | 8-K | 3.1 | 0412/2023 | |
| 3.7 | Certificate of Amendment to Certificate of Incorporation of SOBR Safe, Inc. dated September 25, 2024 | 8-K | 3.1 | 10/01/2024 | |
| 3.8 | Certificate of Amendment to Certificate of Incorporation of SOBR Safe, Inc. dated March 30, 2025 | 8-K | 3.1 | 04/04/2025 | |
| 4.1 | Form of Representative’s Warrant between SOBR Safe, Inc. and Aegis Capital Corp. | 8-K | 4.1 | 05/19/2022 | |
| 4.2 | Warrant Agency Agreement between SOBR Safe, Inc. and Equiniti Trust Company dated May 17, 2022 | 8-K | 4.2 | 05/19/2022 | |
| 4.3 | Form of Unit Warrant, issued May 18, 2022 | 8-K | 4.3 | 05/19/2022 | |
| 4.4 | Warrant to Purchase Common Stock dated June 5, 2020 issued to IDTEC, LLC | 8-K | 10.5 | 06/11/2020 | |
| 4.5 | Warrant to Purchase Common Stock issued by SOBR Safe, Inc. to Armistice Capital Master Fund Ltd. dated September 27, 2021 | 8-K | 10.2 | 10/01/2021 | |
| 4.6 | Form of Warrant issued by SOBR Safe, Inc. in Regulation D Offering | S-1/A | 10.22 | 12/01/2021 | |
| 4.7 | Common Stock Purchase Warrant issued by SOBR Safe, Inc. to Armistice Capital Master Fund Ltd dated March 30, 2022 | S-1 | 10.30 | 09/16/2022 | |
| 4.8 | Form of Senior Convertible Note between SOBR Safe, Inc. and Holders dated March 9, 2023 | 8-K | 10.3 | 03/13/2023 | |
| 4.9 | Common Stock Purchase Warrant between SOBR Safe, Inc. and Holders dated March 9, 2023 | 8-K | 10.4 | 03/13/2023 | |
| 4.10 | Amended And Restated Common Stock Purchase Warrant dated September 30, 2022 issued by SOBR Safe, Inc. to Armistice Capital Master Fund Ltd. amending the original warrant dated March 30, 2022 | S-1 | 10.35 | 10/14/2022 | |
| 4.11 | Amended And Restated Common Stock Purchase Warrant dated September 30, 2022 issued by SOBR Safe, Inc. to Armistice Capital Master Fund Ltd. amending the original warrant dated September 27, 2021 | S-1 | 10.36 | 10/14/2022 | |
| 4.12 | Form of New Warrant | 8-K | 10.2 | 06/04/2024 | |
| 4.13 | Form of Series A Warrant | 8-K | 10.2 | 10/10/2024 | |
| 4.14 | Form of Series B Warrant | 8-K | 10.3 | 10/10/2024 | |
| 4.15 | Form of Prefunded Warrant | 8-K | 10.5 | 10/10/2024 | |
| 4.16 | Description of Securities | 10-K | 4.18 | 04/15/2025 | |
| 4.17 | Form of Pre-Funded Warrant | 8-K | 10.2 | 12/30/2025 | |
| 4.18 | Form of Series C Warrant | 8-K | 10.3 | 12/30/2025 | |
| 4.19 | Form of Series D Warrant | 8-K | 10.4 | 12/30/2025 | |
| 4.20 | Description of Company’s Securities | X | |||
| 10.1 | TransBiotec, Inc. 2019 Equity Incentive Plan | 8-K | 10.1 | 11/19/2019 | |
| 10.2 | Form of Warrant Agreement by and between SOBR Safe, Inc. and Purchasers dated September 30, 2022 | 8-K/A | 10.4 | 10/14/2022 | ||
| 10.3 | Executive Employment Agreement with David Gandini dated January 30th, 2023 | 8-K | 10.1 | 02/03/2023 | ||
| 10.4 | Form of Inducement Letter | 8-K | 10.1 | 03/05/2024 | ||
| 10.5 | Form of Inducement Letter | 8-K | 10.1 | 06/04/2024 | ||
| 10.6 | Form of Securities Purchase Agreement | 8-K | 10.1 | 10/10/2024 | ||
| 10.7 | Form of Registration Rights Agreement | 8-K | 10.4 | 10/10/2024 | ||
| 10.8 | Placement Agent Agreement | 8-K | 10.6 | 10/10/2024 | ||
| 10.9 | Employment Agreement between the Company and CFO effective March 1, 2025 | 8-K | 10.1 | 05/13/2025 | ||
| 10.10 | Form of Securities Purchase Agreement | 8-K | 10.1 | 12/30/2025 | ||
| 10.11 | Form of Registration Rights Agreement | 8-K | 10.5 | 12/30/2025 | ||
| 10.12 | Placement Agent Agreement | 8-K | 10.6 | 12/30/2025 | ||
| 10.13 | Form of Placement Agent Warrant | 8-K | 10.7 | 12/30/2025 | ||
| 10.14 | Amendment No. 1 to Executive Employment Agreement dated December 30, 2025 | 8-K | 10.1 | 01/02/2026 | ||
| 10.15 | Amendment No. 1 to SOBR Safe, Inc. Executive Employment Agreement dated December 30, 2025 | 8-K | 10.2 | 01/02/2026 | ||
| 14.1 | SOBR Safe, Inc. Code of Ethics and Conduct | 10-K | 14 | 04/15/2009 | ||
| 19.1 | SOBR Safe, Inc. Insider Trading Policy | 10-K | 19.1 | 04/15/2025 | ||
| 21.1 | List of Subsidiaries | 10-K | 21.1 | 03/31/2023 | ||
| 23.1 | Consent of Independent Registered Public Accounting Firm | X | ||||
| 24.1 | Power of Attorney (included on the signature page hereto) | X | ||||
| 31.1 | Principal Executive Officer Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Principal Financial Officer Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1 | Principal Executive Officer Certification Pursuant to Item 601(b)(32) of Regulation S-K, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.2 | Principal Financial Officer Certification Pursuant to Item 601(b)(32) of Regulation S-K, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 97.1 | Compensation Recovery Policy | 10-K | 97.1 | 04/01/2024 | ||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |||||
| * | Indicates a management contract or compensatory plan or arrangement. |
|---|
(c) Financial Statement Schedules
Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or the notes thereto.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.